37747311000001107: Vitrakvi 20mg/ml oral solution (Bayer Plc) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Vitrakvi 20mg/ml oral solution (Bayer Plc)
\UK product\Virtual medicinal product\Larotrectinib 20mg/ml oral solution\Vitrakvi 20mg/ml oral solution (Bayer Plc)
\UK product\Virtual therapeutic moiety\Larotrectinib\Larotrectinib 20mg/ml oral solution\Vitrakvi 20mg/ml oral solution (Bayer Plc)
\UK product\Trade family\Vitrakvi\Vitrakvi 20mg/ml oral solution (Bayer Plc)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing larotrectinib (medicinal product)\Larotrectinib\Larotrectinib 20mg/ml oral solution\Vitrakvi 20mg/ml oral solution (Bayer Plc)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing pyrimidine\Product containing larotrectinib (medicinal product)\Larotrectinib\Larotrectinib 20mg/ml oral solution\Vitrakvi 20mg/ml oral solution (Bayer Plc)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing larotrectinib (medicinal product)\Larotrectinib\Larotrectinib 20mg/ml oral solution\Vitrakvi 20mg/ml oral solution (Bayer Plc)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing larotrectinib (medicinal product)\Larotrectinib\Larotrectinib 20mg/ml oral solution\Vitrakvi 20mg/ml oral solution (Bayer Plc)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Oct 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

425551000001118 Vitrakvi 20mg/ml oral solution (Bayer Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

425561000001115 Vitrakvi 20mg/ml oral solution (Bayer Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Vitrakvi 20mg/ml oral solution (Bayer Plc)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Vitrakvi 20mg/ml oral solution (Bayer Plc)	Has excipient	Propylene glycol	false	Inferred relationship	Existential restriction modifier
Vitrakvi 20mg/ml oral solution (Bayer Plc)	Is a	Larotrectinib 20mg/ml oral solution	true	Inferred relationship	Existential restriction modifier
Vitrakvi 20mg/ml oral solution (Bayer Plc)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Vitrakvi 20mg/ml oral solution (Bayer Plc)	Has excipient	Hydroxybenzoates	false	Inferred relationship	Existential restriction modifier
Vitrakvi 20mg/ml oral solution (Bayer Plc)	Is a	Vitrakvi	true	Inferred relationship	Existential restriction modifier
Vitrakvi 20mg/ml oral solution (Bayer Plc)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Larotrectinib	false	Inferred relationship	Existential restriction modifier
Vitrakvi 20mg/ml oral solution (Bayer Plc)	Has specific active ingredient	Larotrectinib sulfate	false	Inferred relationship	Existential restriction modifier
Vitrakvi 20mg/ml oral solution (Bayer Plc)	VMP non-availability indicator	Available	false	Inferred relationship	Existential restriction modifier
Vitrakvi 20mg/ml oral solution (Bayer Plc)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Vitrakvi 20mg/ml oral solution (Bayer Plc)	Has dispensed dose form	Conventional release oral solution	true	Inferred relationship	Existential restriction modifier
Vitrakvi 20mg/ml oral solution (Bayer Plc)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Vitrakvi 20mg/ml oral solution (Bayer Plc)	Has specific active ingredient	Larotrectinib sulfate	true	Inferred relationship	Existential restriction modifier
Vitrakvi 20mg/ml oral solution (Bayer Plc)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only	true	Inferred relationship	Existential restriction modifier
Vitrakvi 20mg/ml oral solution (Bayer Plc)	Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator	EMA (European Medicines Agency) monitoring	true	Inferred relationship	Existential restriction modifier
Vitrakvi 20mg/ml oral solution (Bayer Plc)	VMP non-availability indicator	Not available	true	Inferred relationship	Existential restriction modifier
Vitrakvi 20mg/ml oral solution (Bayer Plc)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Larotrectinib	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Vitrakvi 20mg/ml oral solution (Bayer Plc) 100 ml	Has AMP	True	Vitrakvi 20mg/ml oral solution (Bayer Plc)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
425551000001118	Vitrakvi 20mg/ml oral solution (Bayer Plc)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
425561000001115	Vitrakvi 20mg/ml oral solution (Bayer Plc) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module